Director/PDMR Shareholding

Synexus Clinical Research PLC 06 February 2007 Synexus Clinical Research PLC 6 February 2007 Directors Shareholdings The Company received notification today that following a purchase on 5 February 2007 of 15,000 ordinary 10p shares in the Company at a price of 65p each, Malcolm Hughes, Non-Executive Director of the Company, is now interested in 15,000 ordinary shares representing 0.065% of the issued share capital of that class. The Company also received notification today that following a purchase on 5 February 2007 of 15,000 ordinary 10p shares in the Company at a price of 65p each, Michael Fort, Chief Executive of the Company, is now interested in 1,976,739 ordinary shares representing 8.54% of the issued share capital of that class. The Company further received notification today that following a purchase on 5 February 2007 of 15,000 ordinary 10p shares in the Company at a price of 65p each Michael Redmond, Executive Chairman of the Company, is now interested in 1,616,674 ordinary shares representing 6.98% of the issued share capital of that class. This information is provided by RNS The company news service from the London Stock Exchange

Companies

Synectics (SNX)
UK 100